Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Inventory Average (2016 - 2018)

Theravance Biopharma (TBPH) has disclosed Inventory Average for 5 consecutive years, with $17.9 million as the latest value for Q3 2018.

  • On a quarterly basis, Inventory Average rose 30.84% to $17.9 million in Q3 2018 year-over-year; TTM through Sep 2018 was $17.9 million, a 30.84% increase, with the full-year FY2017 number at $14.5 million, up 30.71% from a year prior.
  • Inventory Average was $17.9 million for Q3 2018 at Theravance Biopharma, up from $17.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $17.9 million in Q3 2018 to a low of $9.6 million in Q2 2016.
  • A 5-year average of $13.2 million and a median of $12.7 million in 2017 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: fell 22.8% in 2016, then soared 38.6% in 2018.
  • Theravance Biopharma's Inventory Average stood at $13.8 million in 2014, then dropped by 19.98% to $11.1 million in 2015, then grew by 11.53% to $12.4 million in 2016, then grew by 29.91% to $16.0 million in 2017, then increased by 11.66% to $17.9 million in 2018.
  • Per Business Quant, the three most recent readings for TBPH's Inventory Average are $17.9 million (Q3 2018), $17.6 million (Q2 2018), and $17.0 million (Q1 2018).